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Abstract
Introduction: The goals of this study were (i) to compare the prevalence of focal knee abnormalities, the mean
cartilage T2 relaxation time, and the spatial distribution of cartilage magnetic resonance (MR) T2 relaxation times
between subjects with and without risk factors for Osteoarthritis (OA), (ii) to determine the relationship between
MR cartilage T2 parameters, age and cartilage morphology as determined with whole-organ magnetic resonance
imaging scores (WORMS) and (iii) to assess the reproducibility of WORMS scoring and T2 relaxation time
measurements including the mean and grey level co-occurrence matrix (GLCM) texture parameters.
Methods: Subjects with risk factors for OA (n = 92) and healthy controls (n = 53) were randomly selected from the
Osteoarthritis Initiative (OAI) incidence and control cohorts, respectively. The specific inclusion criteria for this study
were (1) age range 45-55 years, (2) body mass index (BMI) of 19-27 kg/m2, (3) Western Ontario and McMaster
University (WOMAC) pain score of zero and (4) Kellgren Lawrence (KL) score of zero at baseline. 3.0 Tesla MR
images of the right knee were analyzed using morphological gradings of cartilage, bone marrow and menisci
(WORMS) as well as compartment specific cartilage T2 mean and heterogeneity. Regression models adjusted for
age, gender, and BMI were used to determine the difference in cartilage parameters between groups.
Results: While there was no significant difference in the prevalence of knee abnormalities (cartilage lesions, bone
marrow lesions, meniscus lesions) between controls and subjects at risk for OA, T2 parameters (mean T2, GLCM
contrast, and GLCM variance) were significantly elevated in those at risk for OA. Additionally, a positive significant
association between cartilage WORMS score and cartilage T2 parameters was evident.
Conclusions: Overall, this study demonstrated that subjects at risk for OA have both higher and more heterogeneous
cartilage T2 values than controls, and that T2 parameters are associated with morphologic degeneration.
Introduction
Osteoarthritis (OA) is a degenerative joint disease that
affects more than 27 million people in the US alone [1].
OA is characterized by biochemical and morphologic
degradation of joint tissues (in particular, the articular
hyaline cartilage). The process of cartilage loss is mani-
fested by biochemical degeneration (proteoglycan loss,
increased water content, collagen degradation, and
chondrocyte response to tissue damage) as well as mor-
phologic degeneration such as fibrillation and cartilage
thinning [2,3]. Biochemical alterations to the articular
cartilage often occur prior to morphologic degeneration
[4]; thus, evaluating the biochemical composition of car-
tilage may be valuable for the early detection of OA.
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Magnetic resonance (MR) T2 relaxation time is sensi-
tive to biochemical changes that occur during cartilage
degeneration, including alterations in hydration, collagen
content, and tissue anisotropy [5]. Mean cartilage T2 has
been used to distinguish subjects with early OA from
healthy subjects [6]. Recent studies have suggested that,
in addition to mean T2, the spatial distribution of carti-
lage T2 values may be important when examining the
pathogenesis of OA [7-9]. Early degenerative changes of
the cartilage matrix due to disease or injury are reflected
by the spatial distribution of T2 values and can be quan-
tified by grey level co-occurrence matrix (GLCM) tex-
ture analysis [10]. GLCM entropy of cartilage T2 has
been found to be elevated in patients with OA as com-
pared with controls [7,9], demonstrating that not only
mean T2 [6] but also the spatial distribution of T2 values
is affected by disease.
The Osteoarthritis Initiative (OAI) is a multi-center
longitudinal study aimed at assessing biomarkers in OA,
including those derived from MR imaging (MRI). The
OAI is a cross-sectional and longitudinal dataset that
includes both MRI and radiographic images of subjects,
scanned annually over 4 years. MR images that can be
used to assess joint morphology and cartilage T2 are
available. This database provides a means to longitudin-
ally evaluate MRI biomarkers, including T2 relaxation
time in the development and progression of OA, thus
providing a wealth of information on OA development
and progression.
While many previous studies have evaluated subjects
with symptomatic and radiographic OA [11-13], the pre-
sent study evaluates subjects at risk for developing OA
(but without radiographic knee degeneration or pain
within the week before MRI) as well as normal controls.
This patient cohort is unique, facilitating the assessment
of early biochemical changes in OA which occur prior
to morphologic degeneration detected by radiography.
Since early morphologic degeneration in the joint may
not be detected by radiography [14,15], this study uses
MRI to assess cartilage and meniscus morphology. The
MR whole-organ magnetic resonance imaging scores
(WORMS) [16] are employed for focal knee evaluation,
and MR T2 relaxation time is used for the assessment of
cartilage biochemical composition. The goals of this
study were (a) to compare the prevalence of focal knee
abnormalities, the mean cartilage T2 relaxation time,
and the spatial distribution of cartilage MR T2 relaxation
times between subjects with risk factors for OA and
those without them; (b) to determine the relationship
between MR cartilage T2 parameters, age, and cartilage
morphology as determined by WORMS; and (c) to
assess the reproducibility of WORMS scoring and T2




A subset of subjects from the incidence (n = 92) and
control (n = 53) cohorts of the OAI [17] was selected
on the basis of the inclusion criteria of this study. The
incidence cohort did not have symptomatic knee OA -
criteria were no ‘frequent knee symptoms in the past 12
months, defined as “pain, aching, or stiffness in or
around the knee on most days” for at least 1 month
during the past 12 months, and no radiographic tibiofe-
moral knee OA, defined as definite tibiofemoral osteo-
phytes (Osteoarthritis Research Society International
atlas grades 1 to 3, equivalent to Kellgren-Lawrence
(KL) grade of at least 2 on fixed flexion radiographs in
either knee at baseline)’ [17] - but did have risk factors
for OA, including being overweight (defined using gen-
der- and age-specific cut-points for weight: males of
greater than 92.9 kg and females of greater than 77.1 kg
from the age of 45 to 69 years) or having knee injury
(defined as a history of knee injury causing difficulty
walking for at least 1 week), knee surgery (defined as a
history of knee surgery, including meniscal and ligamen-
tous repairs and unilateral total knee replacement for
OA), family history of total knee replacement (defined
as a total knee replacement for OA in a biological par-
ent or sibling), or Heberden nodes (defined as self-
report of bony enlargement of 1+ distal interphalangeal
joint in both hands) [17]. Subjects from the control
cohort had no knee symptoms or risk factors for OA.
The exclusion criteria for the study included rheumatoid
arthritis, bilateral total knee joint replacement, and a
positive pregnancy test. The specific inclusion criteria
for this study were (a) age range of 45 to 55 years, (b)
body mass index (BMI) of 19 to 27 kg/m2, (c) Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) pain score of 0, and (d) KL score of 0 at
baseline. These parameters were chosen in order to
examine a middle-aged, non-obese, and asymptomatic
population without radiographic evidence of OA. The
following OAI datasets were assessed in this study: base-
line clinical dataset 0.2.2 and baseline imaging datasets
0.E.1 and 0.C.2. The institutional review boards at all
units participating in the OAI, including the clinical
centers and the OAI Coordinating Center at University
of California San Francisco, have reviewed and approved
the protocol and consent forms for the OAI study. All
OAI study participants signed informed consent forms
for participation in the study.
Knee radiographs
Bilateral standing posterior-anterior fixed flexion knee
radiographs were acquired at baseline. Knees were posi-
tioned in a plexiglass frame (SynaFlexer; CCBR-Synarc,
Newark, CA, USA) with 20° to 30° flexion and 10°
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internal rotation of the feet. In an additional reading
performed for the present study, knee radiographs were
graded by two radiologists (LN and WV) in consensus
by using the KL scoring system [18]. The KL score
included only the tibiofemoral joint and not the patello-
femoral joint since the OAI used the posterior-anterior
‘fixed flexion’ knee radiograph protocol, which is a pri-
mary protocol for tibiofemoral joint radiography.
Magnetic resonance imaging
MR images were obtained with four identical 3.0 Tesla
scanners (Siemens Magnetom Trio, Erlangen, Germany)
and quadrature transmit-receive coils (USA Instruments,
Aurora, OH, USA) in Columbus, OH; Baltimore, MD;
Pittsburgh, PA; and Pawtucket, RI. The following
sequences were acquired and used for image analysis:
sagittal two-dimensional (2D) intermediate-weighted
(IW) fast spin-echo (FSE) sequence (resolution = 0.357
× 0.511 × 3.0 mm) and a coronal 2D IW FSE sequence
(resolution = 0.365 × 0.456 × 3.0 mm). A sagittal 2D
multi-slice multi-echo (MSME) sequence (TE1-TE7 =
10, 20, 30, 40, 50, 60, 70 ms, resolution = 0.313 × 0.446
× 3.0 mm, and 0.5 mm gap) was used for T2 measure-
ments [19].
Image analysis
All images were analyzed with a Sun Workstation (Sun
Microsystems, now part of Oracle Corporation, Red-
wood Shores, CA, USA). Knee articular cartilage was
segmented manually in five compartments (patella, med-
ial femur, medial tibia, lateral femur, and lateral tibia) as
previously reported [20,21]. An IDL (Interactive Data
Language, Research Systems, Boulder, CO, USA) soft-
ware routine was implemented to manually segment the
cartilage from the T2 maps by one operator (HA). Seg-
mentation was performed on a slice-by-slice basis (span-
ning all slices), and each region of interest encompassed
the entirety of the cartilage tissue. To exclude potential
chemical shift artifacts or fluid from the region of inter-
est, the user simultaneously examined the T2 map and
the first echo of the MSME sequence (in neighboring
image panels) with synchronized cursor, slice number,
and zoom.
T2 maps were computed on the basis of Equation 1
from the MSME images on a pixel-by-pixel basis by
using six echoes (TE = 20 to 70 ms) and three para-






In Equation 1, S is the signal intensity at a given echo
time (TE), S0 is the signal intensity at TE = 0 ms, and B
is the estimated noise at a given TE. To reduce potential
errors resulting from stimulated echoes in a multi-echo
Carr-Purcell-Meiboom-Gill sequence [24,25], the first
echo (TE = 10 ms) was not included in the T2 fitting
procedure. A noise-corrected algorithm was implemen-
ted based on results from a recent study demonstrating
increased accuracy and precision of T2 relaxation time
when using a noise-corrected algorithm as compared
with the traditional uncorrected exponential fit [22,23].
T2 quantification was performed with an in-house pro-
gram created with Matlab (MathWorks, Natick, MA,
USA).
Texture analysis
Texture analysis was performed on a slice-by-slice basis
on the cartilage T2 maps. This method is based on the
GLCM as described by Haralick and colleagues [10].
The GLCM determines the frequency that neighboring
grey-level values occur in an image. GLCM texture
parameters, including contrast, variance, and entropy,
were calculated in each cartilage region. The equations























P(i, j)(i − j)2 (4)
P represents the probability of the co-occurrence of
pixel values i and j in an image. N represents the total
number of pixel value co-occurrences in the image. A
pixel offset of one pixel was chosen based on the fact
that approximately three to four pixels span the cartilage
thickness. Analysis was performed by averaging the
GLCM parameters across four orientations: 0° (corre-
sponding to the anterior-posterior axis), 45°, 90° (corre-
sponding to the superior-inferior axis), and 135°.
WORMS scoring
MR images of the right knee were reviewed on picture
archiving communication system workstations (Agfa,
Ridgefield Park, NJ, USA). A board-certified radiologist
(WV) with 7 years of experience and a fourth-year
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radiology resident (LN) with 3 years of experience read
the images independently and graded meniscus, carti-
lage, and bone marrow lesions. Cartilage and bone mar-
row lesions were assessed in five compartments (patella,
medial femur, medial tibia, lateral femur, and lateral
tibia) by using a modified semi-quantitative WORMS
[16,26,27], and the highest grade of lesion was recorded
for each region. In case of disagreement, a consensus
reading was performed with a musculoskeletal radiolo-
gist with 22 years of experience (TML). For calibration
purposes, the first 20 cases were read simultaneously by
the three readers in consensus. Compared with the ori-
ginal WORMS grading system, only six compartments
were analyzed as relatively mild lesions were expected.
This could have potentially affected the number of
grade 4 or grade 6 cartilage lesions as well as grade 3
bone marrow lesions, all of which, however, are rare.
Cartilage signal and morphology were scored with an 8-
point scale: 0 = normal thickness and signal, 1 = normal
thickness but increased signal on T2-weighted images,
2.0 = partial-thickness focal defect of less than 1 cm in
greatest width, 2.5 = full-thickness focal defect of less
than 1 cm in greatest width, 3 = multiple areas of par-
tial-thickness (grade 2.0) defects intermixed with areas
of normal thickness or a grade 2.0 defect of wider than
1 cm but less than 75% of the region, 4 = diffuse (at
least 75% of the region) partial-thickness loss, 5 = multi-
ple areas of full-thickness loss (grade 2.5) or a grade 2.5
lesion of wider than 1 cm but less than 75% of the
region, and 6 = diffuse (at least 75% of the region) full-
thickness loss. Meniscal morphology was assessed in six
regions by using a modified WORMS: the medial and
lateral sides of the anterior, body, and posterior regions;
an additional grade was added to the meniscal classifica-
tion ‘intrasubstance degeneration’ to better assess early
degenerative disease. The grading scale ranged from 1
to 4: 0 = normal, 1 = intrasubstance abnormalities, 2 =
non-displaced tear, 3 = displaced or complex tear, and 4
= complete destruction. Subarticular bone marrow
abnormalities were defined as poorly marginated areas
of increased signal intensity in the normal subchondral
and epiphyseal bone marrow on T2-weighted FSE fast-
suppressed MR images. A 4-point grading scale was
employed to assess the size of the bone marrow
abnormalities: 0 = none, 1 = minimal (less than 25% of
region), 2 = moderate (25% to 50% of region), and 3 =
severe (greater than 50% of region) [20].
Reproducibility
The reproducibility of WORMS scoring for meniscus,
cartilage, and bone marrow tissues was investigated in
15 subjects and read out twice by two radiologists inde-
pendently. An intraclass correlation coefficient (ICC)
was calculated to determine the intra- and inter-reader
reproducibility errors [28]. The ICC is mathematically
equal to the weighted kappa using quadratic weights
[29,30]. The reproducibility of mean T2 and texture ana-
lysis was determined by segmenting the cartilage in five
subjects, three times by one operator (HA). The repro-
ducibility error was calculated as the root mean square
(RMS) coefficient of variation (CV) of the repeated mea-
surements as described by Glüer and colleagues [31].
Statistical analysis
Statistical analysis was performed with STATA 11 soft-
ware (StataCorp LP, College Station, TX, USA). Descrip-
tive statistics (i.e. mean age, gender, and BMI) were
calculated for each group, and differences between
groups were assessed by using regression models and a
Pearson chi-square test. The association between age
and mean T2 was assessed by using regression models
and partial correlations adjusting for group, gender, and
BMI.
The primary compartmental predictors of this study
were the medial femur, the medial tibia, and the average
of all compartments. The medial femur and medial tibia
were chosen based on the following rationale: the med-
ial side of the knee is a concentrated region of weight-
bearing [32], the medial side of the knee has a higher
incidence of OA than the lateral side [33], and meniscal
and cartilage lesions are more prevalent on the medial
side of the joint [33]. The remaining compartments,
including the lateral femur, lateral tibia, and patella,
were examined in an exploratory manner. Additionally,
three GLCM texture parameters were analyzed (GLCM
contrast, GLCM variance, and GLCM entropy) and were
regarded as representative parameters from each of the
three texture groups (contrast, statistics, and order,
respectively). These texture parameters were selected
based on of results from previous studies demonstrating
their elevation in subjects with OA [7-9].
Two separate analyses were performed to assess the
prevalence of morphologic knee abnormalities in each
group: the first analysis defined the prevalence of carti-
lage (and meniscus) lesions as present for any compart-
ment that had WORMS of greater than 0. The second
analysis defined prevalence as present for any compart-
ment that had WORMS of at least 2. The rationale for
these chosen cutoff points was to assess subjects with
any features of cartilage degeneration (WORMS of
greater than 0) and subjects with mild degeneration
(WORMS of at least 2). The prevalence of subjects with
severe degeneration (WORMS of greater than 4) [34]
was scarce (5 subjects overall); thus, this study did not
focus on these subjects. The differences in the preva-
lence of morphologic knee abnormalities between
groups were assessed by using logistic regression models
(independent variable: group; dependent variable:
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WORMS prevalence). The prevalence of bone marrow
lesions was defined as a BML score greater than 0, and
a logistic regression model (described above) was per-
formed to assess the differences in the prevalence of
bone marrow lesions between groups.
The differences in T2 parameters between control
group (CG) and incidence group (IG) were assessed by
using regression models (independent variables: group;
dependent variable: T2 parameters). To compare the dif-
ferences in T2 parameters between groups, the following
equation was implemented: (T2_parameterIG - T2_para-
meterCG)/(the average standard deviation (SD) of both
groups).
The relationship between the prevalence of morpholo-
gic abnormalities and cartilage T2 was investigated by
using regression models and partial correlations (inde-
pendent variables: T2 parameter and group; dependent
variable: ‘WORMS max score’). The WORMS max score
is defined as the maximum of the WORMS in all com-
partments per patient. All models were adjusted for age,
gender, and BMI.
Results
The control (n = 53) and incidence (n = 92) groups had
no significant differences (P > 0.05) in age or BMI (age-
control = 50.30 ± 3.03 years, ageincidence = 50.65 ± 2.89
years, P = 0.49; BMIcontrol = 23.90 ± 2.23 kg/m
2, BMIinci-
dence = 23.78 ± 2.25 kg/m
2, P = 0.78). The incidence
group consisted of 50 (54.34%) females, whereas the
control group consisted of 36 (67.92%) (P > 0.05) (Table
1). The incidence group had the following distribution
of risk factors: 44 had a previous injury, 19 had previous
knee surgery, 19 had a family history of knee replace-
ment, and 17 had Heberden nodes.
The reproducibility results for the WORMS grading
are listed in Table 2. The intra-observer reproducibility
in all tissues (meniscus, cartilage, and bone marrow)
was at least 96%, whereas the inter-observer reproduci-
bility was at least 97%. The reproducibility results for
the mean cartilage T2 and the GLCM texture analysis
are listed in Table 3. The mean T2 values had RMS CVs
ranging from 0.85% in the lateral femur to 2% in the
medial tibia. GLCM entropy exhibited the lowest CVs
(<1%), whereas GLCM contrast had CVs of less than 5%
in all compartments except for the lateral tibia (8.67%)
and medial tibia (11.41%). The CVs for GLCM variance
were less than 5%, except for the medial tibia, which
had a CV of 7.91%.
A significant association (r = 0.19, P = 0.04) was evi-
dent between subject age and mean T2 (adjusting for
group, gender, and BMI) in all compartments combined
for both the incidence and control groups. The GLCM
texture parameters and WORMS max scores were not
significantly related to age (P > 0.05) in both groups.
The prevalence of focal knee abnormalities (cartilage
lesions, bone marrow lesions, and meniscus lesions) was
not significantly (P > 0.05) different between the inci-
dence and control groups (Tables 4, 5, 6). No significant
differences between groups were observed when evaluat-
ing the overall prevalence of knee abnormalities (Table
4) or the prevalence of knee abnormalities by compart-
ment (Tables 5 and 6). The patella had the highest pre-
valence of cartilage defects (WORMS of greater than 0:
54.5% in the incidence cohort and 57.7% in the control
cohort), followed by the lateral tibia (WORMS of greater
than 0: 19.3% in the incidence cohort and 22.2% in the
control cohort). Also, mensical tears were most abun-
dant in the medial posterior compartment (WORMS of
greater than 0: 43.1% in the incidence group and 33.3%
in the control group), followed by the medial body
(WORMS of greater than 0: 12.5% in the incidence
group and 20.0% in the control group).
The global mean T2, GLCM contrast, and GLCM var-
iance (medial femur, medial tibia, and average of all
compartments) were significantly (P < 0.05) elevated in
Table 1 Subject characteristics
Characteristic Incidence cohort Control cohort P value
Number of subjects 92 53
Age in years, mean ± SD 50.65 ± 2.89 50.30 ± 3.03 0.49a
Body mass index in kg/m2, mean ± SD 23.78 ± 2.25 23.90 ± 2.23 0.78a
Number of females 50 36 0.10b
WOMAC pain score 0 0
Kellgren-Lawrence score 0 0
aRegression model; bPearson chi-square test. SD, standard deviation; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
Table 2 Interclass correlation coefficient [28] of the
whole-organ magnetic resonance imaging scores
(WORMS) in the meniscus, cartilage, and bone marrow
lesions
Tissue Reader 1 Reader 2 ICC
Meniscus 0.98 0.96 0.97
Cartilage 0.98 0.96 0.98
Bone marrow lesions 0.98 0.97 0.98
The reproducibility of WORMS scores was investigated in 15 subjects and read
out twice by two readers independently. ICC, interclass correlation coefficient.
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the incidence group compared with the control group.
Mean T2 in the medial femur was greater in the inci-
dence cohort (37.68 ± 2.28 ms) than in the control
cohort (36.85 ± 2.16 ms). GLCM entropy (medial femur,
medial tibia, and average of all compartments) was ele-
vated in the incidence group but the differences were
not significant (P > 0.05). Table 7 summarizes the aver-
age values of T2 parameters in the incidence and control
groups. An additional exploratory analysis of remaining
compartments demonstrated similar results, but they
were not significant. Subjects at risk for OA had ele-
vated mean T2, GLCM contrast, and GLCM variance in
the lateral femur (P > 0.05), the lateral tibia (P > 0.05),
and the patella (P > 0.05). The incidence and control
groups had a 0.21 SD difference in mean T2, a 0.28 SD
difference in entropy, a 0.31 SD difference in variance,
and a 0.14 SD difference in entropy (average of all com-
partments). Figure 1 illustrates two representative T2
maps from a control and a subject at risk for OA,
respectively. While both subjects do not have cartilage
abnormalities (WORMS = 0), the subject from the inci-
dence cohort has greater mean T2, GLCM contrast,
GLCM variance, and GLCM entropy of cartilage T2.
Subjects with cartilage abnormalities (cartilage
WORMS of greater than 0: n = 92) had significantly (P
< 0.05) elevated cartilage T2 parameters (mean T2,
GLCM variance, GLCM contrast, and GLCM entropy)
than subjects without abnormalities (WORMS = 0: n =
41) in the average of all compartments, in the medial
femur, and the patella. The remaining compartments
did not demonstrate a significant relationship (P > 0.05).
This analysis pooled the incidence and control cohorts
and accounted for group in the regression model. Simi-
lar trends were observed when subdividing the analysis
by group. Note that eight subjects from the control
group and four subjects from the incidence group did
not have WORMS readings available. Figure 2 illustrates
that the mean T2, GLCM contrast, GLCM variance, and
GLCM entropy are significantly elevated in subjects
with cartilage abnormalities.
A positive relationship between cartilage WORMS
max score and T2 parameters (mean cartilage T2 (partial
correlation adjusting for age, gender, and BMI) r = 0.31,
P = 0.0007), GLCM variance (r = 0.18, P = 0.04), GLCM
contrast (r = 0.17, P = 0.03), and GLCM entropy (r =
0.31, P = 0.09) was demonstrated in the medial femur
and across both the control and incidence groups. The
remaining compartments demonstrated similar trends
but the correlations were not significant (P > 0.05).
Table 3 Reproducibility (coefficient of variation) [31] of
T2 measurements in five subjects segmented three times
each by one operator
Medial Lateral
Parameter Femur Tibia Femur Tibia Patella
Mean T2 0.99 2.08 0.85 1.51 0.86
Contrast 4.60 11.41 3.61 8.67 4.07
Entropy 0.47 0.75 0.05 0.03 0.55
Variance 2.40 7.91 2.12 4.31 3.34
The texture parameters analyzed were at 0 degrees and at 1 pixel offset.
Table 4 Prevalence of focal knee abnormalities in the incidence and control groups
Lesion Control groupa (n = 53) Incidence groupa (n = 92) Odds ratiob 95% confidence interval
Cartilage
WORMS >0 33 (73.3%) 59 (67.0%) 0.83 0.36 1.88
WORMS ≥2 19 (42.2%) 44 (50.0%) 1.42 0.66 3.05
Bone marrow lesions 19 (42.2%) 29 (32.9%) 0.64 0.29 1.40
Meniscus
WORMS >0 18 (40.0%) 42 (47.7%) 1.52 0.71 3.30
WORMS ≥2 9 (15.5%) 22 (25.0%) 2.16 0.73 6.35
aEight subjects from the control group and four subjects from the incidence group did not have whole-organ magnetic resonance imaging score (WORMS)
readings available. bAll P values were greater than 0.05 using a logistic regression both when unadjusted and when adjusted for age, body mass index, and
gender.
Table 5 Prevalence of cartilage abnormalities (cartilage
WORMS >0 and WORMS ≥2) in the incidence and control
groups by compartment
Prevalence of WORMS >0
Medial Lateral
Groupa, b Femur Tibia Femur Tibia Patella






















Prevalence of WORMS ≥2
Medial Lateral
Groupa, b Femur Tibia Femur Tibia Patella




















aAll P values were greater than 0.05 using a logistic regression both when
unadjusted and when adjusted for age, body mass index, and gender. bEight
subjects from the control group and four subjects from the incidence group
did not have whole-organ magnetic resonance imaging score (WORMS)
readings available. Various subjects had lesions in multiple compartments.
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Discussion
This study evaluated the differences in knee morphology
and biochemical composition in the incidence and con-
trol groups of the OAI. While there was no significant
difference in the prevalence of knee abnormalities (carti-
lage lesions, bone marrow lesions, and meniscus lesions)
between the incidence and control groups, T2 para-
meters (mean T2, GLCM contrast, and GLCM variance)
were significantly elevated in the incidence group. These
results demonstrate that subjects at risk for OA may
experience early breakdown of the cartilage extracellular
matrix (ECM), such as changes to the collagen structure
and increased mobility of water, prior to cartilage
degeneration. It is interesting that both subject groups
had neither pain (WOMAC pain = 0) nor radiographic
evidence (KL score of 0 in the tibiofemoral joint) of OA
at baseline yet had varying biochemical compositions.
These results suggest that T2 mapping may be useful in
detecting early arthritic biochemical cartilage changes
that precede morphologic degeneration in OA.
While radiography did not demonstrate joint space
narrowing or osteophytes in either subject group, MRI
detected cartilage and meniscus defects in both groups.
The patellar cartilage had the highest prevalence of
abnormalities compared with the other compartments,
and this corroborates previous studies in athletes [35],
candidates for cartilage repair surgery [36], and controls
and subjects who developed frequent knee symptoms
over 15 months [34]. The posterior horn of the medial
meniscus had the highest prevalence of meniscus degen-
eration, and this has been previously reported [37-39].
Previous studies have demonstrated discordant findings
between radiographic and arthroscopic joint damage:
subjects with normal radiographic KL scores often
demonstrated advanced OA when arthroscopy was used
[14]. Thus, soft tissue degeneration in the knee may not
Table 6 Prevalence of meniscus abnormalities (meniscus WORMS >0 and WORMS ≥2) in the incidence and control
groups by compartment
Prevalence of WORMS >0
Medial Lateral
Groupa, b Anterior Body Posterior Anterior Body Posterior
Incidence group (n = 92) 1 (1.1%) 11 (12.5%) 38 (43.1%) 6 (6.8%) 4 (4.5%) 10 (11.3%)
Control group (n = 53) 0 (0.0%) 9 (20.0%) 15 (33.3%) 1 (2.2%) 0 (0.0%) 5 (11.1%)
Prevalence of WORMS ≥2
Medial Lateral
Groupa, b Anterior Body Posterior Anterior Body Posterior
Incidence group (n = 92) 0 (0.0%) 7 (8.3%) 18 (26.4%) 3 (3.5%) 1 (1.1%) 0 (0.0%)
Control group (n = 53) 0 (0.0%) 5 (12.2%) 5 (14.2%) 1 (2.2%) 0 (0.0%) 1 (2.4%)
aAll P values were greater than 0.05 using a logistic regression both when unadjusted and when adjusted for age, body mass index, and gender. bEight subjects
from the control group and four subjects from the incidence group did not have whole-organ magnetic resonance imaging score (WORMS) readings available.
Various subjects had lesions in multiple compartments.
Table 7 Average values of T2 parameters in the incidence and control groups
Parameter Compartmenta Incidence group (n =
92)











All 32.65 ± 1.55 32.07 ± 1.38 0.056 0.018 -0.72 -1.31 -0.12
MF 37.68 ± 2.28 36.85 ± 2.16 0.042 0.003 -1.18 -1.94 -0.42
MT 30.27 ± 1.88 29.51 ± 1.77 0.029 0.036 -0.72 -1.39 -0.04
GLCM Contrast All 248.67 ± 38.39 227.41 ± 35.00 0.005 0.003 -22.81 -37.48 -8.13
MF 364.17 ± 68.98 333.37 ± 66.58 0.013 0.009 -32.97 -57.72 -8.21
MT 257.30 ± 63.19 226.96 ± 47.83 0.004 0.013 -25.40 -45.49 -5.48
Entropy All 6.34 ± 0.16 6.30 ± 0.19 0.142 0.286 -0.03 -0.10 0.03
MF 6.96 ± 0.17 6.90 ± 0.17 0.055 0.062 -0.06 -0.12 0.003
MT 6.17 ± 0.28 6.09 ± 0.34 0.050 0.127 -0.07 -0.15 0.02
Variance All 187.77 ± 26.69 171.74 ± 24.57 0.003 0.002 -16.60 -27.09 -6.27
MF 255.64 ± 42.38 233.10 ± 38.60 0.003 0.001 -24.86 -39.82 -9.91
MT 183.65 ± 37.88 162.66 ± 32.01 0.001 0.005 -17.89 -30.31 -5.47
aAll, average of all compartments: medial femur (MF), medial tibia (MT), lateral femur, lateral tibia, and patella. bP value adjusted for age, gender, and body mass
index (BMI). cThe coefficient is the difference in the T2 parameter between the incidence and control groups, adjusted for age, gender, and BMI. A coefficient
below 0 indicates that the control group has a lower estimated T2 parameter in comparison with the incidence group. GLCM, grey level co-occurrence matrix.
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closely correspond with joint space narrowing [14,15],
and radiography may not be optimal for assessing early-
stage arthritic joint degeneration.
Interestingly, the prevalence of cartilage and meniscus
morphologic abnormalities was similar between controls
and subjects at risk for OA. One might expect that sub-
jects at risk for OA may have an increased number of
morphologic abnormalities; however, this was not the
case in this study. Similar results were reported in a
study by Crema and colleagues [39], who demonstrated
that the prevalence of meniscal abnormalities was simi-
lar between patients with OA (frequent knee symptoms
and KL score of 2 to 3) and controls. In addition, Javaid
and colleagues [34] reported that the prevalence of carti-
lage lesions (any feature damage, whole knee) was simi-
lar between OA subjects (KL score of 0 at baseline) who
developed frequent knee symptoms over 15 months
(80.6%) and controls (67.2%); however, severe cartilage
lesions were significantly more prevalent in subjects
with OA (22.2% in subjects with OA and 8.6% in con-
trols). The results of these studies suggest that control
subjects have a similar prevalence of morphologic
abnormalities as those at risk for OA and those with
mild/moderate OA; thus, the use of morphologic grad-
ing to discriminate between subjects with early OA and
controls may be challenging.
While the prevalence of morphologic abnormalities
was similar between groups, the mean T2 significantly
differed, indicating that subjects at risk for OA have
altered cartilage biochemistry. Cartilage T2 relaxation
time is sensitive to the mobility of water in cartilage tis-
sue [40], water content [41], and collagen fiber orienta-
tion [42]; changes to these elements of the ECM
characterize the initial stages of early OA, eventually
leading to gross joint degeneration as detected by mor-
phologic MRI. The elevation of cartilage T2 suggests
that early cartilage biochemical changes may be of pri-
mary interest when assessing subjects at risk for OA.
While elevated mean T2 values are associated with
OA, the heterogeneous nature of cartilage tissue is also
an important consideration when quantifying cartilage
tissue integrity. Nissi and colleagues [43] reported that
healthy bovine cartilage samples showed a laminar
appearance while spontaneously degenerated bovine car-
tilage tissue did not, demonstrating changes in the dis-
tribution of cartilage ECM components with
degeneration. In addition, previous studies have shown
varying T2 relaxation times from the cartilage-bone
interface to the joint surface [24,40,44-47] and varying
spatial patterns of T2 values in osteoarthritic cartilage
[48]. Therefore, quantifying only mean values of carti-
lage T2 may mask important information regarding the
Figure 1 Representative T2 maps from a subject from the control cohort (left) and a subject from the incidence cohort (right). Cartilage
T2 maps are median-filtered with a 3 × 3 kernal for visualization. Both subjects have no cartilage abnormalities (cartilage whole-organ magnetic
resonance imaging scores (WORMS) = 0) and no pain (Western Ontario and McMaster Universities Osteoarthritis Index pain = 0); however, the
subject from the incidence cohort has elevated mean T2 (39.12 versus 33.39 ms), elevated grey level co-occurrence matrix (GLCM) variance
(311.63 versus 190.50), elevated GLCM contrast (466.16 versus 266.82), and elevated GLCM entropy (7.17 versus 6.80). Also, the control subject has
intrasubstance abnormalities in the medial posterior meniscus (meniscus WORMS = 1). All other meniscus regions had no abnormalities
(meniscus WORMS = 0).
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spatial changes occurring in the ECM during
degeneration.
The results of this study demonstrated that subjects at
risk for OA have localized variations in their cartilage
composition, as evidenced by their elevated GLCM con-
trast, GLCM entropy, and GLCM variance. Specifically,
GLCM contrast is a measure of the differences in neigh-
boring pixel values; high contrast signifies that many
pixels with different values are neighboring. GLCM
entropy is a measure of disorder in an image; high
entropy signifies that the probability of pixel co-occur-
rence is uniform throughout an image. GLCM variance
is a measure of the distribution of pixels about the
mean; high variance signifies a high dispersion of co-
occurrences of relaxation times. Previous studies have
demonstrated differences in the spatial distribution of
cartilage relaxation times in subjects with OA and those
without OA. For example, Carballido-Gamio and
colleagues [9] demonstrated elevated GLCM contrast
and GLCM entropy of T1 relaxation time in rotating
frame (T1r) and T2 in subjects with mild OA as com-
pared with controls; Li and colleagues [8] demonstrated
elevated GLCM contrast and entropy of patellar carti-
lage T1r in patients with OA compared with controls;
and Blumenkrantz and colleagues [7] demonstrated ele-
vated GLCM entropy of cartilage T2 in patients with
OA as compared with controls. Additionally, Burstein
and colleagues [49] illustrated a loss of normal spatial
dependency of cartilage T2 relaxation times in a patient
with anterior knee pain and chronic chondral injury.
The authors suggested that areas of high T2-weighted
signal (frequently associated with cartilage injury) are
often adjacent to areas with low T2. Such degenerative
changes in cartilage tissue due to disease or injury are
reflected by the spatial distribution of T2 values and can
be quantified by GLCM texture analysis.
Figure 2 Comparison of T2 and texture parameters in subjects with cartilage abnormalities and those without them. Subjects with
cartilage abnormalities (cartilage whole-organ magnetic resonance imaging scores (WORMS) of greater than 0, n = 92) have elevated mean T2,
grey level co-occurrence matrix (GLCM) entropy, GLCM contrast, and GLCM variance in comparison with subjects without abnormalities (cartilage
WORMS = 0, n = 41). Values are averaged among all compartments.
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This study demonstrated that cartilage abnormalities
were associated with elevated and more heterogeneous
cartilage T2 values, corroborating previous research: Blu-
menkrantz and colleagues [50] found an association
between cartilage T2 and cartilage thickness, Mosher
and colleagues [51] reported changes in cartilage T2 and
cartilage thickness after running, Stahl and colleagues
[52] reported associations between cartilage T2 and car-
tilage volume and thickness, and Stehling and colleagues
[20] demonstrated a relationship between patellar carti-
lage T2 and cartilage morphology (WORMS). These
results highlight the complex interrelationship between
biochemical cartilage changes and consequent morpho-
logic cartilage loss and suggest that biochemical carti-
lage composition as measured by T2 may be associated
with cartilage loss.
Several limitations are pertinent to this study: it may
have been useful to subdivide the cartilage into weight-
bearing and non-weight-bearing regions. To minimize
errors due to multiple comparisons, this type of segmen-
tation was not performed. Furthermore, other techni-
ques such as dGEMRIC (delayed gadolinium-enhanced
MRI of cartilage) or T1r may have been useful in inves-
tigating the ECM during OA progression; however, this
study did not employ these methods, as the required
MRI sequences were not acquired in the OAI protocol.
Because the feasibility of GLCM texture analysis by
using the OAI dataset was demonstrated by Carballido-
Gamio and colleagues [53], their study provided the
foundation for the present study. The present study
evaluated a larger subject cohort (145 versus 13 sub-
jects), examined distinct subject groups (we examined
subjects at risk for OA and healthy controls while Car-
ballido-Gamio and colleagues [53] examined subjects
with symptomatic and radiographic OA), and assessed
joint morphology in addition to cartilage T2. Thus, the
present study is unique in assessing the spatial distribu-
tion of cartilage T2 values by using GLCM texture ana-
lysis in a large cohort at risk for OA.
Conclusions
This study demonstrated that subjects at risk for OA
have both higher and more heterogeneous T2 values
than controls and that subjects with cartilage abnormal-
ities have elevated cartilage T2 parameters compared
with subjects without abnormalities. While joint mor-
phology was similar in both groups, cartilage T2 para-
meters showed significant differences, suggesting that T2
relaxation time may be a valuable early marker for OA.
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